Keyphrases
Locoregional Treatment
100%
Hepatic Malignancy
100%
Vandetanib
100%
Radiopaque Beads
100%
Drug-eluting Beads
83%
DC Bead
33%
Drug Loading
33%
Tyrosine Kinase Inhibitor
33%
Radiopaque
33%
Small Molecules
16%
Drug Release
16%
Treatment Options
16%
Binding Capacity
16%
Fourier Transform Infrared Spectroscopy (FT-IR)
16%
Sustained Release
16%
Embolization
16%
Hepatocellular Carcinoma
16%
Locoregional Drug Delivery
16%
Release Rate
16%
Locoregional
16%
Shrinkage Effect
16%
Multiple Sites
16%
Energy Dispersive X-ray Spectroscopy
16%
Radiopacity
16%
Infrared Energy
16%
Downstream Consequences
16%
Vascular Endothelial Growth Factor Receptor (VEGFR)
16%
Intra-arterial Delivery
16%
Liver Tumor
16%
Bromine Atom
16%
Antiangiogenic
16%
Loading Solution
16%
Cardiac Toxicity
16%
Bead-based
16%
Transarterial Treatment
16%
Antiproliferative Activity
16%
Protonation
16%
Hydrophobic Nature
16%
Ionic Interaction
16%
Epithelial Growth Factor Receptor
16%
Drug Choice
16%
Drug Interactions
16%
Pharmacology, Toxicology and Pharmaceutical Science
Vandetanib
100%
Protein Tyrosine Kinase Inhibitor
33%
Drug Release
16%
Sustained Release
16%
Liver Cell Carcinoma
16%
Liver Tumor
16%
Growth Factor Receptor
16%
Antiangiogenic
16%
Drug Interaction
16%
Fourier Transform Infrared Spectroscopy
16%
Cardiotoxicity
16%
Vasculotropin Receptor
16%